- Home
- NERV vs DATS Comparison
NERV vs DATS Comparison
Compare NERV & DATS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- DATS
- Stock Information
- Founded
- NERV 2007
- DATS 2014
- Country
- NERV United States
- DATS United States
- Employees
- NERV N/A
- DATS N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- DATS Computer Software: Prepackaged Software
- Sector
- NERV Health Care
- DATS Technology
- Exchange
- NERV Nasdaq
- DATS Nasdaq
- Market Cap
- NERV 12.4M
- DATS 10.4M
- IPO Year
- NERV 2014
- DATS 2021
- Fundamental
- Price
- NERV $1.59
- DATS $2.70
- Analyst Decision
- NERV Hold
- DATS
- Analyst Count
- NERV 1
- DATS 0
- Target Price
- NERV $5.00
- DATS N/A
- AVG Volume (30 Days)
- NERV 7.7K
- DATS 144.1K
- Earning Date
- NERV 05-20-2025
- DATS 05-20-2025
- Dividend Yield
- NERV N/A
- DATS N/A
- EPS Growth
- NERV N/A
- DATS N/A
- EPS
- NERV 0.19
- DATS N/A
- Revenue
- NERV N/A
- DATS $436.00
- Revenue This Year
- NERV N/A
- DATS N/A
- Revenue Next Year
- NERV N/A
- DATS N/A
- P/E Ratio
- NERV $8.42
- DATS N/A
- Revenue Growth
- NERV N/A
- DATS N/A
- 52 Week Low
- NERV $1.15
- DATS $1.01
- 52 Week High
- NERV $3.69
- DATS $9.34
- Technical
- Relative Strength Index (RSI)
- NERV 46.58
- DATS 55.59
- Support Level
- NERV $1.65
- DATS $2.15
- Resistance Level
- NERV $1.75
- DATS $2.70
- Average True Range (ATR)
- NERV 0.08
- DATS 0.22
- MACD
- NERV -0.00
- DATS 0.04
- Stochastic Oscillator
- NERV 31.03
- DATS 95.63
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About DATS DatChat Inc.
DatChat Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts.